Mopidralazine hydrochloride
Mopidralazine hydrochloride (MDL-899) (Compound 30) is an orally active antihypertensive agent. Mopidralazine hydrochloride significantly reduces systolic blood pressure (ED50 = 1.94 mg/kg) in spontaneously hypertensive rats models. Mopidralazine hydrochloride has a slower onset of action but a longer duration of action and has a significantly smaller effect on increasing heart rate in canine model of renal hypertension. Mopidralazine hydrochloride can be used for the research of hypertension.
For research use only. We do not sell to patients.
- CAS No.: 86703-02-8
- Formula: C14H20ClN5O
- Molecular Weight:309.79
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Chemical Information
-
CAS No. 86703-02-8
-
Molecular Weight 309.79
-
Formula C14H20ClN5O
-
SMILES
CC1=CC=C(C)N1NC2=NN=C(N3CCOCC3)C=C2.Cl
-
Synonyms
MDL-899
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)